1. Turner P.V., et, al. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011. 50, 600-613. 2. Oral gavage in mice and rats iacuc standard procedure. 2020. 3. Injection Techniques, Restraint, &Handling for Mice and Rats. 4. Al Shoyaib A., et, al. Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies? Pharm Res. 2019. 37, 12. 5. Kris A., et, al. Intraperitoneal (IP) Injection in Rats and Mice. UBC Animal Care Guidelines. 2014. 6. Turner P.V., et, al. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011. 50, 600-613. 7. Li J.L., et, al. Intravital multiphoton imaging of immune responses in the mouse ear skin. Nat Protoc. 2012. 7, 221-234. 8. Masuda J, et, al. Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities. Oncol Rep. 2017. 38, 449-455. 9. Braid L.R., et, al. Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes. Cytotherapy. 2018. 20, 232-244. 10. Pal A., et, al. Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation. Anticancer Res. 2005. 25, 331-41. 11. Shingo H., et, al. Chapter Twenty-Three-Tumor Formation Assays. Methods in Enzymology. 2010. 497, 397-411. 12. Banks WA. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov. 2016. 15, 275-92. 13. Shin MK, et, al. Reducing acetylated tau is neuroprotective in brain injury. Cell. 2021. 184, 2715-2732.